ZHISHAN WEIXIN BIOTECHNOLOGY
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
ZHISHAN WEIXIN BIOTECHNOLOGY
Industry:
Biotechnology Health Care Product Research
Founded:
2018-01-01
Address:
Chengdu, Sichuan, China
Country:
China
Status:
Active
Total Funding:
0
Investors List
Delian Capital
Delian Capital investment in Series A - Zhishan Weixin Biotechnology
Morningside Group
Morningside Group investment in Series A - Zhishan Weixin Biotechnology
Leimei Ruisi
Leimei Ruisi investment in Series A - Zhishan Weixin Biotechnology
Sichuan Talent Fund
Sichuan Talent Fund investment in Series A - Zhishan Weixin Biotechnology
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences investment in Series A - Zhishan Weixin Biotechnology
Zhengxingu Capital
Zhengxingu Capital investment in Series A - Zhishan Weixin Biotechnology